Recent studies targeting glutamate [99] and glucagon [100] receptors have demonstrated remarkable efficacy on human type 1 diabetes pancreas slices and type 1 diabetes mouse models in normalising glucagon secretion and improving beta cell mass, respectively. The gene discussed is GCG; the disease is type 1 diabetes mellitus.